company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q1,,2014-03-31,2014-05-08 16:05:39+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,144893000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q1,,2014-03-31,2014-05-08 16:05:39+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,2673000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q1,,2014-03-31,2014-05-08 16:05:39+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,147566000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q1,,2014-03-31,2014-05-08 16:05:39+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,322000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q1,,2014-03-31,2014-05-08 16:05:39+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,997000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q1,,2014-03-31,2014-05-08 16:05:39+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,400000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q1,,2014-03-31,2014-05-08 16:05:39+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,1397000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q1,,2014-03-31,2014-05-08 16:05:39+00:00,,totalassets,Total Assets,=,debit,usd,149285000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q1,,2014-03-31,2014-05-08 16:05:39+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,3273000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q1,,2014-03-31,2014-05-08 16:05:39+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,1550000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q1,,2014-03-31,2014-05-08 16:05:39+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,57000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q1,,2014-03-31,2014-05-08 16:05:39+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,135000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q1,,2014-03-31,2014-05-08 16:05:39+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,5015000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q1,,2014-03-31,2014-05-08 16:05:39+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,170000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q1,,2014-03-31,2014-05-08 16:05:39+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,170000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q1,,2014-03-31,2014-05-08 16:05:39+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,5185000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q1,,2014-03-31,2014-05-08 16:05:39+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q1,,2014-03-31,2014-05-08 16:05:39+00:00,totalliabilitiesandequity,redeemablenoncontrollinginterest,Redeemable Noncontrolling Interest,+,credit,usd,0.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q1,,2014-03-31,2014-05-08 16:05:39+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q1,,2014-03-31,2014-05-08 16:05:39+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,220363000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q1,,2014-03-31,2014-05-08 16:05:39+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-76263000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q1,,2014-03-31,2014-05-08 16:05:39+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,144100000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q1,,2014-03-31,2014-05-08 16:05:39+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,144100000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q1,,2014-03-31,2014-05-08 16:05:39+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,144100000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q1,,2014-03-31,2014-05-08 16:05:39+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,149285000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q2,,2014-06-30,2014-08-07 07:53:39+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,132307000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q2,,2014-06-30,2014-08-07 07:53:39+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,2976000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q2,,2014-06-30,2014-08-07 07:53:39+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,135283000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q2,,2014-06-30,2014-08-07 07:53:39+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,604000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q2,,2014-06-30,2014-08-07 07:53:39+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,1392000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q2,,2014-06-30,2014-08-07 07:53:39+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,400000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q2,,2014-06-30,2014-08-07 07:53:39+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,1792000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q2,,2014-06-30,2014-08-07 07:53:39+00:00,,totalassets,Total Assets,=,debit,usd,137679000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q2,,2014-06-30,2014-08-07 07:53:39+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,3456000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q2,,2014-06-30,2014-08-07 07:53:39+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,2003000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q2,,2014-06-30,2014-08-07 07:53:39+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,58000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q2,,2014-06-30,2014-08-07 07:53:39+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,130000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q2,,2014-06-30,2014-08-07 07:53:39+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,5647000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q2,,2014-06-30,2014-08-07 07:53:39+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,201000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q2,,2014-06-30,2014-08-07 07:53:39+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,151000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q2,,2014-06-30,2014-08-07 07:53:39+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,352000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q2,,2014-06-30,2014-08-07 07:53:39+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,5999000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q2,,2014-06-30,2014-08-07 07:53:39+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q2,,2014-06-30,2014-08-07 07:53:39+00:00,totalliabilitiesandequity,redeemablenoncontrollinginterest,Redeemable Noncontrolling Interest,+,credit,usd,0.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q2,,2014-06-30,2014-08-07 07:53:39+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q2,,2014-06-30,2014-08-07 07:53:39+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,224374000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q2,,2014-06-30,2014-08-07 07:53:39+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-92694000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q2,,2014-06-30,2014-08-07 07:53:39+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,131680000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q2,,2014-06-30,2014-08-07 07:53:39+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,131680000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q2,,2014-06-30,2014-08-07 07:53:39+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,131680000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q2,,2014-06-30,2014-08-07 07:53:39+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,137679000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q3,,2014-09-30,2014-11-10 16:18:00+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,227131000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q3,,2014-09-30,2014-11-10 16:18:00+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,4215000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q3,,2014-09-30,2014-11-10 16:18:00+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,231346000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q3,,2014-09-30,2014-11-10 16:18:00+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,2734000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q3,,2014-09-30,2014-11-10 16:18:00+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,675000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q3,,2014-09-30,2014-11-10 16:18:00+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,400000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q3,,2014-09-30,2014-11-10 16:18:00+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,1075000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q3,,2014-09-30,2014-11-10 16:18:00+00:00,,totalassets,Total Assets,=,debit,usd,235155000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q3,,2014-09-30,2014-11-10 16:18:00+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,2102000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q3,,2014-09-30,2014-11-10 16:18:00+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,3649000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q3,,2014-09-30,2014-11-10 16:18:00+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,156000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q3,,2014-09-30,2014-11-10 16:18:00+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,327000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q3,,2014-09-30,2014-11-10 16:18:00+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,6234000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q3,,2014-09-30,2014-11-10 16:18:00+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,1117000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q3,,2014-09-30,2014-11-10 16:18:00+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,1117000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q3,,2014-09-30,2014-11-10 16:18:00+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,7351000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q3,,2014-09-30,2014-11-10 16:18:00+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q3,,2014-09-30,2014-11-10 16:18:00+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,340222000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q3,,2014-09-30,2014-11-10 16:18:00+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-112418000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q3,,2014-09-30,2014-11-10 16:18:00+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,227804000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q3,,2014-09-30,2014-11-10 16:18:00+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,227804000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q3,,2014-09-30,2014-11-10 16:18:00+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,227804000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q3,,2014-09-30,2014-11-10 16:18:00+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,235155000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q1,,2015-03-31,2015-05-11 16:02:18+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,51453000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q1,,2015-03-31,2015-05-11 16:02:18+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,194956000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q1,,2015-03-31,2015-05-11 16:02:18+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,2910000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q1,,2015-03-31,2015-05-11 16:02:18+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,249319000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q1,,2015-03-31,2015-05-11 16:02:18+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,3282000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q1,,2015-03-31,2015-05-11 16:02:18+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,38539000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q1,,2015-03-31,2015-05-11 16:02:18+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,500000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q1,,2015-03-31,2015-05-11 16:02:18+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,400000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q1,,2015-03-31,2015-05-11 16:02:18+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,39439000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q1,,2015-03-31,2015-05-11 16:02:18+00:00,,totalassets,Total Assets,=,debit,usd,292040000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q1,,2015-03-31,2015-05-11 16:02:18+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,6957000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q1,,2015-03-31,2015-05-11 16:02:18+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,7417000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q1,,2015-03-31,2015-05-11 16:02:18+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,200000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q1,,2015-03-31,2015-05-11 16:02:18+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,128000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q1,,2015-03-31,2015-05-11 16:02:18+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,14702000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q1,,2015-03-31,2015-05-11 16:02:18+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,1813000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q1,,2015-03-31,2015-05-11 16:02:18+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,1813000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q1,,2015-03-31,2015-05-11 16:02:18+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,16515000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q1,,2015-03-31,2015-05-11 16:02:18+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q1,,2015-03-31,2015-05-11 16:02:18+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,439918000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q1,,2015-03-31,2015-05-11 16:02:18+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-164412000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q1,,2015-03-31,2015-05-11 16:02:18+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,19000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q1,,2015-03-31,2015-05-11 16:02:18+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,275525000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q1,,2015-03-31,2015-05-11 16:02:18+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,275525000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q1,,2015-03-31,2015-05-11 16:02:18+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,275525000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q1,,2015-03-31,2015-05-11 16:02:18+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,292040000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q2,,2015-06-30,2015-08-10 07:01:16+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,24231000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q2,,2015-06-30,2015-08-10 07:01:16+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,196955000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q2,,2015-06-30,2015-08-10 07:01:16+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,4066000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q2,,2015-06-30,2015-08-10 07:01:16+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,225252000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q2,,2015-06-30,2015-08-10 07:01:16+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,3234000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q2,,2015-06-30,2015-08-10 07:01:16+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,34407000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q2,,2015-06-30,2015-08-10 07:01:16+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,0.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q2,,2015-06-30,2015-08-10 07:01:16+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,400000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q2,,2015-06-30,2015-08-10 07:01:16+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,34807000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q2,,2015-06-30,2015-08-10 07:01:16+00:00,,totalassets,Total Assets,=,debit,usd,263293000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q2,,2015-06-30,2015-08-10 07:01:16+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,4469000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q2,,2015-06-30,2015-08-10 07:01:16+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,9333000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q2,,2015-06-30,2015-08-10 07:01:16+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,200000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q2,,2015-06-30,2015-08-10 07:01:16+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,97000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q2,,2015-06-30,2015-08-10 07:01:16+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,14099000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q2,,2015-06-30,2015-08-10 07:01:16+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,1867000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q2,,2015-06-30,2015-08-10 07:01:16+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,1867000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q2,,2015-06-30,2015-08-10 07:01:16+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,15966000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q2,,2015-06-30,2015-08-10 07:01:16+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q2,,2015-06-30,2015-08-10 07:01:16+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,444578000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q2,,2015-06-30,2015-08-10 07:01:16+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-197108000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q2,,2015-06-30,2015-08-10 07:01:16+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-143000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q2,,2015-06-30,2015-08-10 07:01:16+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,247327000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q2,,2015-06-30,2015-08-10 07:01:16+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,247327000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q2,,2015-06-30,2015-08-10 07:01:16+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,247327000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q2,,2015-06-30,2015-08-10 07:01:16+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,263293000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q3,,2015-09-30,2015-11-09 07:01:02+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,43499000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q3,,2015-09-30,2015-11-09 07:01:02+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,151738000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q3,,2015-09-30,2015-11-09 07:01:02+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,3107000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q3,,2015-09-30,2015-11-09 07:01:02+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,198344000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q3,,2015-09-30,2015-11-09 07:01:02+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,3660000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q3,,2015-09-30,2015-11-09 07:01:02+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,34430000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q3,,2015-09-30,2015-11-09 07:01:02+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,52000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q3,,2015-09-30,2015-11-09 07:01:02+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,485000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q3,,2015-09-30,2015-11-09 07:01:02+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,34967000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q3,,2015-09-30,2015-11-09 07:01:02+00:00,,totalassets,Total Assets,=,debit,usd,236971000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q3,,2015-09-30,2015-11-09 07:01:02+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,4568000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q3,,2015-09-30,2015-11-09 07:01:02+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,9469000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q3,,2015-09-30,2015-11-09 07:01:02+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,200000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q3,,2015-09-30,2015-11-09 07:01:02+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,203000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q3,,2015-09-30,2015-11-09 07:01:02+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,14440000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q3,,2015-09-30,2015-11-09 07:01:02+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,1939000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q3,,2015-09-30,2015-11-09 07:01:02+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,1939000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q3,,2015-09-30,2015-11-09 07:01:02+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,16379000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q3,,2015-09-30,2015-11-09 07:01:02+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q3,,2015-09-30,2015-11-09 07:01:02+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,448099000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q3,,2015-09-30,2015-11-09 07:01:02+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-227481000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q3,,2015-09-30,2015-11-09 07:01:02+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-26000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q3,,2015-09-30,2015-11-09 07:01:02+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,220592000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q3,,2015-09-30,2015-11-09 07:01:02+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,220592000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q3,,2015-09-30,2015-11-09 07:01:02+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,220592000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q3,,2015-09-30,2015-11-09 07:01:02+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,236971000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q1,,2016-03-31,2016-05-09 16:08:19+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,42188000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q1,,2016-03-31,2016-05-09 16:08:19+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,94228000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q1,,2016-03-31,2016-05-09 16:08:19+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1726000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q1,,2016-03-31,2016-05-09 16:08:19+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,138142000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q1,,2016-03-31,2016-05-09 16:08:19+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,3343000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q1,,2016-03-31,2016-05-09 16:08:19+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,50165000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q1,,2016-03-31,2016-05-09 16:08:19+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,485000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q1,,2016-03-31,2016-05-09 16:08:19+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,50650000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q1,,2016-03-31,2016-05-09 16:08:19+00:00,,totalassets,Total Assets,=,debit,usd,192135000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q1,,2016-03-31,2016-05-09 16:08:19+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,4109000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q1,,2016-03-31,2016-05-09 16:08:19+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,8652000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q1,,2016-03-31,2016-05-09 16:08:19+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,263000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q1,,2016-03-31,2016-05-09 16:08:19+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,198000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q1,,2016-03-31,2016-05-09 16:08:19+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,13222000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q1,,2016-03-31,2016-05-09 16:08:19+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,1877000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q1,,2016-03-31,2016-05-09 16:08:19+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,1877000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q1,,2016-03-31,2016-05-09 16:08:19+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,15099000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q1,,2016-03-31,2016-05-09 16:08:19+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q1,,2016-03-31,2016-05-09 16:08:19+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,460528000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q1,,2016-03-31,2016-05-09 16:08:19+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-283586000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q1,,2016-03-31,2016-05-09 16:08:19+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,94000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q1,,2016-03-31,2016-05-09 16:08:19+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,177036000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q1,,2016-03-31,2016-05-09 16:08:19+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,177036000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q1,,2016-03-31,2016-05-09 16:08:19+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,177036000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q1,,2016-03-31,2016-05-09 16:08:19+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,192135000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q2,,2016-06-30,2016-08-04 16:06:53+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,37717000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q2,,2016-06-30,2016-08-04 16:06:53+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,85019000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q2,,2016-06-30,2016-08-04 16:06:53+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1464000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q2,,2016-06-30,2016-08-04 16:06:53+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,124200000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q2,,2016-06-30,2016-08-04 16:06:53+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,3170000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q2,,2016-06-30,2016-08-04 16:06:53+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,42933000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q2,,2016-06-30,2016-08-04 16:06:53+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,111000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q2,,2016-06-30,2016-08-04 16:06:53+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,483000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q2,,2016-06-30,2016-08-04 16:06:53+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,43527000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q2,,2016-06-30,2016-08-04 16:06:53+00:00,,totalassets,Total Assets,=,debit,usd,170897000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q2,,2016-06-30,2016-08-04 16:06:53+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,4063000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q2,,2016-06-30,2016-08-04 16:06:53+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,11112000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q2,,2016-06-30,2016-08-04 16:06:53+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,269000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q2,,2016-06-30,2016-08-04 16:06:53+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,79000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q2,,2016-06-30,2016-08-04 16:06:53+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,15523000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q2,,2016-06-30,2016-08-04 16:06:53+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,1808000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q2,,2016-06-30,2016-08-04 16:06:53+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,1808000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q2,,2016-06-30,2016-08-04 16:06:53+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,17331000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q2,,2016-06-30,2016-08-04 16:06:53+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q2,,2016-06-30,2016-08-04 16:06:53+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,467172000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q2,,2016-06-30,2016-08-04 16:06:53+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-313744000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q2,,2016-06-30,2016-08-04 16:06:53+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,138000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q2,,2016-06-30,2016-08-04 16:06:53+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,153566000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q2,,2016-06-30,2016-08-04 16:06:53+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,153566000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q2,,2016-06-30,2016-08-04 16:06:53+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,153566000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q2,,2016-06-30,2016-08-04 16:06:53+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,170897000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q3,,2016-09-30,2016-11-07 16:25:55+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,43908000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q3,,2016-09-30,2016-11-07 16:25:55+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,82903000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q3,,2016-09-30,2016-11-07 16:25:55+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,3440000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q3,,2016-09-30,2016-11-07 16:25:55+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,130251000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q3,,2016-09-30,2016-11-07 16:25:55+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,2991000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q3,,2016-09-30,2016-11-07 16:25:55+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,49598000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q3,,2016-09-30,2016-11-07 16:25:55+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,299000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q3,,2016-09-30,2016-11-07 16:25:55+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,484000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q3,,2016-09-30,2016-11-07 16:25:55+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,50381000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q3,,2016-09-30,2016-11-07 16:25:55+00:00,,totalassets,Total Assets,=,debit,usd,183623000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q3,,2016-09-30,2016-11-07 16:25:55+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,2193000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q3,,2016-09-30,2016-11-07 16:25:55+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,12309000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q3,,2016-09-30,2016-11-07 16:25:55+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,275000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q3,,2016-09-30,2016-11-07 16:25:55+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,175000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q3,,2016-09-30,2016-11-07 16:25:55+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,14952000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q3,,2016-09-30,2016-11-07 16:25:55+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,1739000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q3,,2016-09-30,2016-11-07 16:25:55+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,1739000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q3,,2016-09-30,2016-11-07 16:25:55+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,16691000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q3,,2016-09-30,2016-11-07 16:25:55+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q3,,2016-09-30,2016-11-07 16:25:55+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,506129000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q3,,2016-09-30,2016-11-07 16:25:55+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-339169000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q3,,2016-09-30,2016-11-07 16:25:55+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-28000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q3,,2016-09-30,2016-11-07 16:25:55+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,166932000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q3,,2016-09-30,2016-11-07 16:25:55+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,166932000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q3,,2016-09-30,2016-11-07 16:25:55+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,166932000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q3,,2016-09-30,2016-11-07 16:25:55+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,183623000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q1,,2017-03-31,2017-05-04 16:07:58+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,25577000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q1,,2017-03-31,2017-05-04 16:07:58+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,200000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q1,,2017-03-31,2017-05-04 16:07:58+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,84307000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q1,,2017-03-31,2017-05-04 16:07:58+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,2146000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q1,,2017-03-31,2017-05-04 16:07:58+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,112230000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q1,,2017-03-31,2017-05-04 16:07:58+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,2654000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q1,,2017-03-31,2017-05-04 16:07:58+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,40257000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q1,,2017-03-31,2017-05-04 16:07:58+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,15000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q1,,2017-03-31,2017-05-04 16:07:58+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,279000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q1,,2017-03-31,2017-05-04 16:07:58+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,40551000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q1,,2017-03-31,2017-05-04 16:07:58+00:00,,totalassets,Total Assets,=,debit,usd,155435000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q1,,2017-03-31,2017-05-04 16:07:58+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,4245000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q1,,2017-03-31,2017-05-04 16:07:58+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,10740000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q1,,2017-03-31,2017-05-04 16:07:58+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,286000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q1,,2017-03-31,2017-05-04 16:07:58+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,210000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q1,,2017-03-31,2017-05-04 16:07:58+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,15481000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q1,,2017-03-31,2017-05-04 16:07:58+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,1591000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q1,,2017-03-31,2017-05-04 16:07:58+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,1591000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q1,,2017-03-31,2017-05-04 16:07:58+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,17072000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q1,,2017-03-31,2017-05-04 16:07:58+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q1,,2017-03-31,2017-05-04 16:07:58+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,534842000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q1,,2017-03-31,2017-05-04 16:07:58+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-396275000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q1,,2017-03-31,2017-05-04 16:07:58+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-204000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q1,,2017-03-31,2017-05-04 16:07:58+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,138363000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q1,,2017-03-31,2017-05-04 16:07:58+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,138363000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q1,,2017-03-31,2017-05-04 16:07:58+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,138363000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q1,,2017-03-31,2017-05-04 16:07:58+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,155435000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q2,,2017-06-30,2017-08-08 16:07:48+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,55381000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q2,,2017-06-30,2017-08-08 16:07:48+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,200000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q2,,2017-06-30,2017-08-08 16:07:48+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,88073000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q2,,2017-06-30,2017-08-08 16:07:48+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,2070000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q2,,2017-06-30,2017-08-08 16:07:48+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,145724000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q2,,2017-06-30,2017-08-08 16:07:48+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,2473000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q2,,2017-06-30,2017-08-08 16:07:48+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,37269000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q2,,2017-06-30,2017-08-08 16:07:48+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,284000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q2,,2017-06-30,2017-08-08 16:07:48+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,37553000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q2,,2017-06-30,2017-08-08 16:07:48+00:00,,totalassets,Total Assets,=,debit,usd,185750000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q2,,2017-06-30,2017-08-08 16:07:48+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,3247000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q2,,2017-06-30,2017-08-08 16:07:48+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,12876000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q2,,2017-06-30,2017-08-08 16:07:48+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,1317000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q2,,2017-06-30,2017-08-08 16:07:48+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,80000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q2,,2017-06-30,2017-08-08 16:07:48+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,17520000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q2,,2017-06-30,2017-08-08 16:07:48+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,1516000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q2,,2017-06-30,2017-08-08 16:07:48+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,1516000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q2,,2017-06-30,2017-08-08 16:07:48+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,19036000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q2,,2017-06-30,2017-08-08 16:07:48+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q2,,2017-06-30,2017-08-08 16:07:48+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,592539000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q2,,2017-06-30,2017-08-08 16:07:48+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-425660000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q2,,2017-06-30,2017-08-08 16:07:48+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-165000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q2,,2017-06-30,2017-08-08 16:07:48+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,166714000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q2,,2017-06-30,2017-08-08 16:07:48+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,166714000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q2,,2017-06-30,2017-08-08 16:07:48+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,166714000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q2,,2017-06-30,2017-08-08 16:07:48+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,185750000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q3,,2017-09-30,2017-11-02 16:21:57+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,54450000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q3,,2017-09-30,2017-11-02 16:21:57+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,200000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q3,,2017-09-30,2017-11-02 16:21:57+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,64956000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q3,,2017-09-30,2017-11-02 16:21:57+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,2076000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q3,,2017-09-30,2017-11-02 16:21:57+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,121682000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q3,,2017-09-30,2017-11-02 16:21:57+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,2304000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q3,,2017-09-30,2017-11-02 16:21:57+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,39498000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q3,,2017-09-30,2017-11-02 16:21:57+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,289000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q3,,2017-09-30,2017-11-02 16:21:57+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,39787000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q3,,2017-09-30,2017-11-02 16:21:57+00:00,,totalassets,Total Assets,=,debit,usd,163773000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q3,,2017-09-30,2017-11-02 16:21:57+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,1890000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q3,,2017-09-30,2017-11-02 16:21:57+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,17715000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q3,,2017-09-30,2017-11-02 16:21:57+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,1348000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q3,,2017-09-30,2017-11-02 16:21:57+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,202000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q3,,2017-09-30,2017-11-02 16:21:57+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,21155000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q3,,2017-09-30,2017-11-02 16:21:57+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,1441000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q3,,2017-09-30,2017-11-02 16:21:57+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,1441000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q3,,2017-09-30,2017-11-02 16:21:57+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,22596000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q3,,2017-09-30,2017-11-02 16:21:57+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q3,,2017-09-30,2017-11-02 16:21:57+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,597567000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q3,,2017-09-30,2017-11-02 16:21:57+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-456300000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q3,,2017-09-30,2017-11-02 16:21:57+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-90000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q3,,2017-09-30,2017-11-02 16:21:57+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,141177000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q3,,2017-09-30,2017-11-02 16:21:57+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,141177000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q3,,2017-09-30,2017-11-02 16:21:57+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,141177000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q3,,2017-09-30,2017-11-02 16:21:57+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,163773000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q1,,2018-03-31,2018-05-10 16:06:51+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,37499000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q1,,2018-03-31,2018-05-10 16:06:51+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,0.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q1,,2018-03-31,2018-05-10 16:06:51+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,93418000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q1,,2018-03-31,2018-05-10 16:06:51+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,2396000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q1,,2018-03-31,2018-05-10 16:06:51+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,133313000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q1,,2018-03-31,2018-05-10 16:06:51+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,2454000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q1,,2018-03-31,2018-05-10 16:06:51+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,10314000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q1,,2018-03-31,2018-05-10 16:06:51+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,292000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q1,,2018-03-31,2018-05-10 16:06:51+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,10606000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q1,,2018-03-31,2018-05-10 16:06:51+00:00,,totalassets,Total Assets,=,debit,usd,146373000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q1,,2018-03-31,2018-05-10 16:06:51+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,4949000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q1,,2018-03-31,2018-05-10 16:06:51+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,21545000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q1,,2018-03-31,2018-05-10 16:06:51+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,19907000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q1,,2018-03-31,2018-05-10 16:06:51+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,333000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q1,,2018-03-31,2018-05-10 16:06:51+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,46734000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q1,,2018-03-31,2018-05-10 16:06:51+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,4110000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q1,,2018-03-31,2018-05-10 16:06:51+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,4110000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q1,,2018-03-31,2018-05-10 16:06:51+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,50844000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q1,,2018-03-31,2018-05-10 16:06:51+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q1,,2018-03-31,2018-05-10 16:06:51+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,629615000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q1,,2018-03-31,2018-05-10 16:06:51+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-533800000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q1,,2018-03-31,2018-05-10 16:06:51+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-286000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q1,,2018-03-31,2018-05-10 16:06:51+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,95529000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q1,,2018-03-31,2018-05-10 16:06:51+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,95529000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q1,,2018-03-31,2018-05-10 16:06:51+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,95529000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q1,,2018-03-31,2018-05-10 16:06:51+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,146373000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q2,,2018-06-30,2018-08-07 17:18:59+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,118966000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q2,,2018-06-30,2018-08-07 17:18:59+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,0.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q2,,2018-06-30,2018-08-07 17:18:59+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,122155000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q2,,2018-06-30,2018-08-07 17:18:59+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,3438000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q2,,2018-06-30,2018-08-07 17:18:59+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,244559000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q2,,2018-06-30,2018-08-07 17:18:59+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,2611000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q2,,2018-06-30,2018-08-07 17:18:59+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,8781000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q2,,2018-06-30,2018-08-07 17:18:59+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,638000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q2,,2018-06-30,2018-08-07 17:18:59+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,9419000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q2,,2018-06-30,2018-08-07 17:18:59+00:00,,totalassets,Total Assets,=,debit,usd,256589000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q2,,2018-06-30,2018-08-07 17:18:59+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,3794000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q2,,2018-06-30,2018-08-07 17:18:59+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,22969000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q2,,2018-06-30,2018-08-07 17:18:59+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,9552000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q2,,2018-06-30,2018-08-07 17:18:59+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,229000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q2,,2018-06-30,2018-08-07 17:18:59+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,36544000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q2,,2018-06-30,2018-08-07 17:18:59+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,6573000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q2,,2018-06-30,2018-08-07 17:18:59+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,6573000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q2,,2018-06-30,2018-08-07 17:18:59+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,43117000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q2,,2018-06-30,2018-08-07 17:18:59+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q2,,2018-06-30,2018-08-07 17:18:59+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,781186000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q2,,2018-06-30,2018-08-07 17:18:59+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-567454000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q2,,2018-06-30,2018-08-07 17:18:59+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-260000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q2,,2018-06-30,2018-08-07 17:18:59+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,213472000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q2,,2018-06-30,2018-08-07 17:18:59+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,213472000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q2,,2018-06-30,2018-08-07 17:18:59+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,213472000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q2,,2018-06-30,2018-08-07 17:18:59+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,256589000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q3,,2018-09-30,2018-11-08 17:12:06+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,101600000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q3,,2018-09-30,2018-11-08 17:12:06+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,0.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q3,,2018-09-30,2018-11-08 17:12:06+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,105170000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q3,,2018-09-30,2018-11-08 17:12:06+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,4792000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q3,,2018-09-30,2018-11-08 17:12:06+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,211562000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q3,,2018-09-30,2018-11-08 17:12:06+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,2914000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q3,,2018-09-30,2018-11-08 17:12:06+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,4804000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q3,,2018-09-30,2018-11-08 17:12:06+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,712000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q3,,2018-09-30,2018-11-08 17:12:06+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,5516000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q3,,2018-09-30,2018-11-08 17:12:06+00:00,,totalassets,Total Assets,=,debit,usd,219992000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q3,,2018-09-30,2018-11-08 17:12:06+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,2238000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q3,,2018-09-30,2018-11-08 17:12:06+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,29155000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q3,,2018-09-30,2018-11-08 17:12:06+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,9618000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q3,,2018-09-30,2018-11-08 17:12:06+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,556000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q3,,2018-09-30,2018-11-08 17:12:06+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,41567000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q3,,2018-09-30,2018-11-08 17:12:06+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,7347000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q3,,2018-09-30,2018-11-08 17:12:06+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,7347000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q3,,2018-09-30,2018-11-08 17:12:06+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,48914000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q3,,2018-09-30,2018-11-08 17:12:06+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q3,,2018-09-30,2018-11-08 17:12:06+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,786769000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q3,,2018-09-30,2018-11-08 17:12:06+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-615538000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q3,,2018-09-30,2018-11-08 17:12:06+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-153000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q3,,2018-09-30,2018-11-08 17:12:06+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,171078000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q3,,2018-09-30,2018-11-08 17:12:06+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,171078000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q3,,2018-09-30,2018-11-08 17:12:06+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,171078000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q3,,2018-09-30,2018-11-08 17:12:06+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,219992000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2019.0,Q1,,2019-03-31,2019-05-09 16:10:09+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,83506000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2019.0,Q1,,2019-03-31,2019-05-09 16:10:09+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,180918000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2019.0,Q1,,2019-03-31,2019-05-09 16:10:09+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,7011000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2019.0,Q1,,2019-03-31,2019-05-09 16:10:09+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,271435000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2019.0,Q1,,2019-03-31,2019-05-09 16:10:09+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,3617000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2019.0,Q1,,2019-03-31,2019-05-09 16:10:09+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,0.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2019.0,Q1,,2019-03-31,2019-05-09 16:10:09+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,11448000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2019.0,Q1,,2019-03-31,2019-05-09 16:10:09+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,714000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2019.0,Q1,,2019-03-31,2019-05-09 16:10:09+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,12162000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2019.0,Q1,,2019-03-31,2019-05-09 16:10:09+00:00,,totalassets,Total Assets,=,debit,usd,287214000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2019.0,Q1,,2019-03-31,2019-05-09 16:10:09+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,2266000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2019.0,Q1,,2019-03-31,2019-05-09 16:10:09+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,28868000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2019.0,Q1,,2019-03-31,2019-05-09 16:10:09+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,10650000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2019.0,Q1,,2019-03-31,2019-05-09 16:10:09+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,2076000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2019.0,Q1,,2019-03-31,2019-05-09 16:10:09+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,43860000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2019.0,Q1,,2019-03-31,2019-05-09 16:10:09+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,104368000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2019.0,Q1,,2019-03-31,2019-05-09 16:10:09+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,3245000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2019.0,Q1,,2019-03-31,2019-05-09 16:10:09+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,14457000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2019.0,Q1,,2019-03-31,2019-05-09 16:10:09+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,122070000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2019.0,Q1,,2019-03-31,2019-05-09 16:10:09+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,165930000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2019.0,Q1,,2019-03-31,2019-05-09 16:10:09+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2019.0,Q1,,2019-03-31,2019-05-09 16:10:09+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,861221000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2019.0,Q1,,2019-03-31,2019-05-09 16:10:09+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-739909000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2019.0,Q1,,2019-03-31,2019-05-09 16:10:09+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-28000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2019.0,Q1,,2019-03-31,2019-05-09 16:10:09+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,121284000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2019.0,Q1,,2019-03-31,2019-05-09 16:10:09+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,121284000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2019.0,Q1,,2019-03-31,2019-05-09 16:10:09+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,121284000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2019.0,Q1,,2019-03-31,2019-05-09 16:10:09+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,287214000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2019.0,Q3,,2019-09-30,2019-11-04 07:23:30+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,168004000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2019.0,Q3,,2019-09-30,2019-11-04 07:23:30+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,99525000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2019.0,Q3,,2019-09-30,2019-11-04 07:23:30+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,7928000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2019.0,Q3,,2019-09-30,2019-11-04 07:23:30+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,100000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2019.0,Q3,,2019-09-30,2019-11-04 07:23:30+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,5310000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2019.0,Q3,,2019-09-30,2019-11-04 07:23:30+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,280867000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2019.0,Q3,,2019-09-30,2019-11-04 07:23:30+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,3240000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2019.0,Q3,,2019-09-30,2019-11-04 07:23:30+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,2022000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2019.0,Q3,,2019-09-30,2019-11-04 07:23:30+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,10904000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2019.0,Q3,,2019-09-30,2019-11-04 07:23:30+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,712000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2019.0,Q3,,2019-09-30,2019-11-04 07:23:30+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,13638000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2019.0,Q3,,2019-09-30,2019-11-04 07:23:30+00:00,,totalassets,Total Assets,=,debit,usd,297745000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2019.0,Q3,,2019-09-30,2019-11-04 07:23:30+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,3068000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2019.0,Q3,,2019-09-30,2019-11-04 07:23:30+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,32421000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2019.0,Q3,,2019-09-30,2019-11-04 07:23:30+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,1053000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2019.0,Q3,,2019-09-30,2019-11-04 07:23:30+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,2660000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2019.0,Q3,,2019-09-30,2019-11-04 07:23:30+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,39202000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2019.0,Q3,,2019-09-30,2019-11-04 07:23:30+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,107962000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2019.0,Q3,,2019-09-30,2019-11-04 07:23:30+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,3479000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2019.0,Q3,,2019-09-30,2019-11-04 07:23:30+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,87232000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2019.0,Q3,,2019-09-30,2019-11-04 07:23:30+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,198673000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2019.0,Q3,,2019-09-30,2019-11-04 07:23:30+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,237875000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2019.0,Q3,,2019-09-30,2019-11-04 07:23:30+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2019.0,Q3,,2019-09-30,2019-11-04 07:23:30+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,884591000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2019.0,Q3,,2019-09-30,2019-11-04 07:23:30+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-824691000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2019.0,Q3,,2019-09-30,2019-11-04 07:23:30+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-30000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2019.0,Q3,,2019-09-30,2019-11-04 07:23:30+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,59870000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2019.0,Q3,,2019-09-30,2019-11-04 07:23:30+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,59870000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2019.0,Q3,,2019-09-30,2019-11-04 07:23:30+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,59870000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2019.0,Q3,,2019-09-30,2019-11-04 07:23:30+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,297745000.0
